References
- Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Ann Rev Neurosci 2001;24:677–736.
- Mathern GW, Babb TL, Leite JP, et al. The pathogenic and progressive features of chronic human hippocampal epilepsy. Epilepsy Res 1996;26(1):151–61.
- Takahashi M, Hayashi S, Kakita A, et al. Patients with temporal lobe epilepsy show an increase in brain-derived neurotrophic factor protein and its correlation with neuropeptide Y. Brain Res. 1999;818(2):579–82.
- Murray KD, Isackson PJ, Eskin TA, et al. Altered mRNA expression for brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase in the hippocampus of patients with intractable temporal lobe epilepsy. J Comp Neurol 2000;418(4):411–22.
- Binder DK, Croll SD, Gall CM, Scharfman HE. BDNF and epilepsy: too much of a good thing? Trends Neurosci. 2001;24(1):47–53.
- Bovolenta R, Zucchini S, Paradiso B, et al. Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures. J Neuroinflamm 2010;7:1–6.
- Egan MF, Kojima M, Callicott JH, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003;112(2):257–69.
- Hall D, Dhilla A, Charalambous A, et al. Sequence variants of the brain-derived neurotrophic factor (BDNF) gene are strongly associated with obsessive-compulsive disorder. Am J Hum Genet 2003;73(2):370–6.
- Geller B, Badner JA, Tillman R, et al. Linkage disequilibrium of the brain-derived neurotrophic factor Val66Met polymorphism in children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry 2004;161(9):1698–700.
- Neves-Pereira M, Cheung JK, Pasdar A, et al. BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol Psychiatry 2005;10(2):208–12.
- Chen SL, Lee SY, Chang YH, et al. The BDNF Val66Met polymorphism and plasma brain-derived neurotrophic factor levels in Han Chinese patients with bipolar disorder and schizophrenia. Prog Neuro-psychopharmacol Biol Psychiatry 2014;51:99–104.
- Kanemoto K, Kawasaki J, Tarao Y, et al. Association of partial epilepsy with brain-derived neurotrophic factor (BDNF) gene polymorphisms. Epilepsy Res 2003;53(3):255–8.
- Lohoff FW, Ferraro TN, Dahl JP, et al. Lack of association between variations in the brain-derived neurotrophic factor (BDNF) gene and temporal lobe epilepsy. Epilepsy Res 2005;66(1–3):59–62.
- Bragatti JA, Schenkel LC, Torres CM, et al. No major clinical impact of Val66Met BDNF gene polymorphism on temporal lobe epilepsy. Epilepsy Res 2010;88(2–3):108–11.
- de Lanerolle NC, Lee TS. New facets of the neuropathology and molecular profile of human temporal lobe epilepsy. Epilepsy Behav 2005;7(2):190–203.
- de Lanerolle NC, Kim JH, Williamson A, et al. A retrospective analysis of hippocampal pathology in human temporal lobe epilepsy: evidence for distinctive patient subcategories. Epilepsia 2003;44(5):677–87.
- Bonilha L, Rorden C, Castellano G, et al. Voxel-based morphometry reveals gray matter network atrophy in refractory medial temporal lobe epilepsy. Arch Neurol 2004;61(9):1379–84.
- Bernasconi N, Duchesne S, Janke A, et al. Whole-brain voxel-based statistical analysis of gray matter and white matter in temporal lobe epilepsy. NeuroImage 2004;23(2):717–23.
- Takaya S, Ikeda A, Mitsueda-Ono T, et al. Temporal lobe epilepsy with amygdala enlargement: a morphologic and functional study. J Neuroimaging 2014;24(1):54–62.
- Li J, Zhang Z, Shang H. A meta-analysis of voxel-based morphometry studies on unilateral refractory temporal lobe epilepsy. Epilepsy Res 2012;98(2–3):97–103.
- Keller SS, Roberts N. Voxel-based morphometry of temporal lobe epilepsy: an introduction and review of the literature. Epilepsia 2008;49(5):741–57.
- Scott RC, King MD, Gadian DG, et al. Hippocampal abnormalities after prolonged febrile convulsion: a longitudinal MRI study. Brain 2003;126(Pt 11):2551–7.
- Yasuda CL, Morita ME, Alessio A, et al. Relationship between environmental factors and gray matter atrophy in refractory MTLE. Neurology 2010;74(13):1062–8.
- Chang Q, Khare G, Dani V, et al. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 2006;49(3):341–8.
- Croll SD, Suri C, Compton DL, et al. Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex. Neuroscience 1999;93(4):1491–506.
- Louhivuori V, Arvio M, Soronen P, et al. The Val66Met polymorphism in the BDNF gene is associated with epilepsy in fragile X syndrome. Epilepsy Res 2009;85(1):114–7.
- Nectoux J, Bahi-Buisson N, Guellec I, et al. The p.Val66Met polymorphism in the BDNF gene protects against early seizures in Rett syndrome. Neurology 2008;70(22 Pt 2):2145–51.
- Ramasamy DP, Ramanathan M, Cox JL, et al. Effect of Met66 allele of the BDNF rs6265 SNP on regional gray matter volumes in patients with multiple sclerosis: a voxel-based morphometry study. Pathophysiology 2011;18(1):53–60.
- Gonul AS, Kitis O, Eker MC,. Association of the brain-derived neurotrophic factor Val66Met polymorphism with hippocampus volumes in drug-free depressed patients. World J Biol Psychiatry 2011;12(2):110–8.
- Kaufman J, Yang BZ, Douglas-Palumberi H, et al. Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry 2006;59(8):673–80.
- Hunnerkopf R, Strobel A, Gutknecht L, et al. Interaction between BDNF Val66Met and dopamine transporter gene variation influences anxiety-related traits. Neuropsychopharmacology 2007;32(12):2552–60.